Switch theme
Sign up to access all valuation multiples
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
1997
109
Last FY Revenue $12.9M
Last FY EBITDA -$3.9M
$24.3M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, aap Implantate achieved revenue of $12.9M and an EBITDA of -$3.9M.
aap Implantate expects next 12-month revenue of XXX and NTM EBITDA of XXX
See aap Implantate valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $12.9M | XXX | XXX | XXX |
| Gross Profit | XXX | $10.9M | XXX | XXX | XXX |
| Gross Margin | XXX | 85% | XXX | XXX | XXX |
| EBITDA | XXX | -$3.9M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -30% | XXX | XXX | XXX |
| EBIT | XXX | -$5.8M | XXX | XXX | XXX |
| EBIT Margin | XXX | -45% | XXX | XXX | XXX |
| Net Profit | XXX | -$5.8M | XXX | XXX | XXX |
| Net Margin | XXX | -45% | XXX | XXX | XXX |
| Net Debt | XXX | $2.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, aap Implantate's stock price is EUR 1 (or $1).
aap Implantate has current market cap of EUR 17.9M (or $20.2M), and EV of EUR 21.6M (or $24.3M).
See aap Implantate trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $24.3M | $20.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, aap Implantate has market cap of $20.2M and EV of $24.3M.
aap Implantate's trades at 1.9x EV/Revenue multiple, and -6.3x EV/EBITDA.
Equity research analysts estimate aap Implantate's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
aap Implantate's P/E ratio is not available.
See valuation multiples for aap Implantate and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $20.2M | XXX | $20.2M | XXX | XXX | XXX |
| EV (current) | $24.3M | XXX | $24.3M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -6.3x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -4.2x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -3.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -6.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free Trialaap Implantate's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.
aap Implantate's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
aap Implantate's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for aap Implantate and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -30% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 130% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
aap Implantate acquired XXX companies to date.
Last acquisition by aap Implantate was XXXXXXXX, XXXXX XXXXX XXXXXX . aap Implantate acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was aap Implantate founded? | aap Implantate was founded in 1997. |
| Where is aap Implantate headquartered? | aap Implantate is headquartered in Germany. |
| How many employees does aap Implantate have? | As of today, aap Implantate has 109 employees. |
| Is aap Implantate publicy listed? | Yes, aap Implantate is a public company listed on ETR. |
| What is the stock symbol of aap Implantate? | aap Implantate trades under AAQ1 ticker. |
| When did aap Implantate go public? | aap Implantate went public in 1999. |
| Who are competitors of aap Implantate? | Similar companies to aap Implantate include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of aap Implantate? | aap Implantate's current market cap is $20.2M |
| Is aap Implantate profitable? | Yes, aap Implantate is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
